PET/CT HCS for therapy response assessment in head and neck cancer serves as a robust Score independent of newer sensitive reconstructions. Despite the high NPV of PET/CT in this situation the unsatisfactory PPV remains challenging.
Leike et al. (Wed,) studied this question.